This activity is designed for physicians, nurses, and pharmacists involved in the clinical care and treatment of patients with multiple myeloma. The program goal is to provide a review of the management of multiple myeloma and examine recent clinical data for emerging treatment strategies and discuss their integration into clinical practice.
This program is sponsored by Medical Education Resources (MER), a non-profit medical education company in Littleton, Colorado and is supported through an educational grant from Tibotec Therapeutics, Division of Ortho Biotech Products, L.P.
The agenda includes:
Primary Treatment Strategies for Multiple Myeloma
Robert Rifkin, MD, FACP
Medical Director
Rocky Mountain Blood and Marrow Transplant Program
US Oncology, Denver, CO
Treatment Strategies for Relapsed/Refractory Multiple Myeloma
Robert Orlowski, MD, PhD
Assistant Professor of Medicine
Lineberger Comprehensive Cancer Center
University of North Carolina, Chapel Hill, NC
There is no fee for participation in this activity. MER designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician’s Recognition Award. For nurses, this program qualifies for 1.25 contact hours. For pharmacists, MER designates this continuing education activity for 1 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.
To view a PDF of the program brochure and registration materials, click here. |
print